Kanagawa, Japan

Keita Hagiya

USPTO Granted Patents = 2 



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Keita Hagiya: Innovator in Pluripotent Stem Cell Research

Introduction

Keita Hagiya is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of pluripotent stem cell research, holding a total of 2 patents. His work focuses on innovative culture methods that enhance the growth and viability of pluripotent stem cells.

Latest Patents

Hagiya's latest patents include a culture method for pluripotent stem cells. This method involves culturing pluripotent stem cells on a specialized cell culture surface using a medium with a low concentration of 2-mercaptoethanol. The presence of a specific polypeptide, which includes critical amino acid sequences, is essential for this process. Another notable patent is related to a polypeptide composition that induces excellent cell growth ability in pluripotent stem cells. This composition contains a multimeric polypeptide derived from human vitronectin, which is crucial for enhancing the culturing properties of these cells.

Career Highlights

Keita Hagiya is currently employed at Fujifilm Corporation, where he continues to advance his research in stem cell technology. His innovative approaches have positioned him as a key figure in the field, contributing to the understanding and application of pluripotent stem cells in various medical and scientific contexts.

Collaborations

Hagiya collaborates with talented coworkers, including Yuta Murakami and Rie Hando. Their combined expertise fosters a productive research environment that drives forward the boundaries of stem cell science.

Conclusion

Keita Hagiya's work in pluripotent stem cell research exemplifies the impact of innovative thinking in biotechnology. His patents and ongoing research contribute significantly to advancements in this vital field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…